AIG Healthcare GP

AIG Healthcare GP

AIG Healthcare GP operates as the dedicated healthcare investment arm of AIG's Japanese insurance platform, formalized to capture innovation tailwinds in an aging society. Kazunori Yasunaga leads the entity from Tokyo, building a portfolio that reflects Japan's national push toward digital health transformation and regenerative medicine. The firm sits inside one of the world's largest insurance franchises but functions with a direct-investment posture unusual for corporate venture arms. The fund targets growth-stage companies spanning digital health platforms, medical devices, and biopharma services, concentrating capital in areas that align with AIG's underwriting insights. Geographic coverage is anchored in Japan with documented co-investments across the US and Southeast Asia. The structure emphasizes direct equity positions and occasionally partners with external GPs on later-stage rounds, though it discloses no anchor limited partners beyond its parent company. Team size and aggregate deployment remain undisclosed. The firm maintains a low public profile consistent with a corporate investment subsidiary, publishing limited performance data or portfolio composition. Adjacent vehicles within the broader AIG Japan ecosystem include traditional general-account fixed-income allocations that supply the liability-matching capital base from which the GP draws its risk budget. The structural differentiator is the GP's dual mandate: it must satisfy the return expectations of an insurance parent while maintaining the speed and specialization of a dedicated sector fund. This tension shapes a portfolio that favors revenue-generating companies with regulatory tailwinds — a posture designed to limit correlation with the parent's broader insurance liabilities.